Cargando…
Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer
Evasion from apoptosis is a hallmark of cancer. Inhibitor of apoptosis proteins (IAPs) contribute to this hallmark by suppressing the induction of cell death. IAPs were found to be overexpressed in cancerous tissues and to contribute to therapeutic resistance. The present review focuses on the IAP m...
Autor principal: | Wolf, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950391/ https://www.ncbi.nlm.nih.gov/pubmed/36845731 http://dx.doi.org/10.3389/fonc.2023.1124600 |
Ejemplares similares
-
X-Linked Inhibitor of Apoptosis Protein – A Critical Death Resistance Regulator and Therapeutic Target for Personalized Cancer Therapy
por: Obexer, Petra, et al.
Publicado: (2014) -
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
por: Golub, Danielle, et al.
Publicado: (2019) -
Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy
por: Lv, Die, et al.
Publicado: (2021) -
Inhibitor of apoptosis proteins as a therapeutic target in breast cancer
por: Foster, FM, et al.
Publicado: (2008) -
Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities
por: Araki, Shinsuke, et al.
Publicado: (2023)